CM
TMO icon

Capula Management’s Thermo Fisher Scientific TMO Stock Holding History

Capula Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$934K Buy
1,900
+700
+58% +$380K 0.01% 376
2025
Q4 		$695K Sell
1,200
-1,500
-56% -$848K ﹤0.01% 344
2025
Q3 		$1.31M Buy
2,700
+2,200
+440% +$1.02M 0.01% 322
2025
Q2 		$203K Sell
500
-1,200
-71% -$502K ﹤0.01% 374
2025
Q1 		$846K Buy
1,700
+1,200
+240% +$650K ﹤0.01% 258
2024
Q4 		$260K Buy
500
+100
+25% +$55K ﹤0.01% 277
2024
Q3 		$247K Sell
400
-400
-50% -$237K ﹤0.01% 345
2024
Q2 		$442K Buy
+800
New +$458K ﹤0.01% 257
2023
Q4 		– Sell
-1,500
Closed -$759K – 568
2023
Q3 		$759K Buy
+1,500
New +$799K 0.02% 271
2023
Q1 		– Sell
-42,100
Closed -$23.2M – 927
2022
Q4 		$23.2M Buy
+42,100
New +$22.3M 0.31% 86
2022
Q3 		– Sell
-20,300
Closed -$11M – 657
2022
Q2 		$11M Buy
+20,300
New +$11.2M 0.19% 131
2021
Q4 		– Sell
-5,400
Closed -$3.08M – 734
2021
Q3 		$3.08M Buy
5,400
+3,000
+125% +$1.65M 0.04% 314
2021
Q2 		$1.21M Sell
2,400
-2,900
-55% -$1.37M 0.02% 357
2021
Q1 		$2.42M Buy
+5,300
New +$2.53M 0.05% 282
2020
Q3 		– Sell
-9,600
Closed -$3.48M – 298
2020
Q2 		$3.48M Buy
+9,600
New +$3.22M 0.12% 161

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capula Management's TMO Position: Q1 2026 in Review

Capula Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 188 shares worth $92.4K. The stake represents ﹤0.01% of the portfolio and ranks #911 among its holdings. This is a return to the name: Capula Management previously reported a position in TMO as recently as Q3 2025.

Capula Management first reported a position in TMO in Q1 2021 and has held it in 13 quarters since. The position peaked at $4.36M in Q2 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Capula Management held 188 shares of Thermo Fisher Scientific worth $92.4K as of Q1 2026.
  • Thermo Fisher Scientific was a new Capula Management position in Q1 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #911 holding.
  • Capula Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 13 quarters since.
  • Capula Management's Thermo Fisher Scientific position peaked at $4.36M in Q2 2022.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.